New Strategic Partnership: CNBE INRS and Wax-it Histology Services Inc.

New Strategic Partnership: CNBE INRS and Wax-it Histology Services Inc.

VANCOUVER, BC AND LAVAL, QC. (April 11, 2018) — Wax-it Histology Services Inc. and CNBE (INRS) are pleased to announce a strategic partnership in the area of contractual research in laboratory animal experimentation and histology analysis services by joining their respective expertise. The new strike force allows the companies to provide an expanded and integrated menu of services making the sponsor’s experiment a complete study that can be customized to customer needs. The menu is as follows: screening toxicology (target organ toxicity identification, maximum tolerated dose, dose-range finding), screening pharmacokinetic and biomarker identification, proof-of-concept studies with numerous animal models and high-quality histology services (histopathology, special staining, immunochemistry, immunofluorescence, resin histology, implantable medical device histology, antibody cross-reactivity, imaging and data analysis).


Wax-it Histology Services Inc., a GLP-compliant histopathology laboratory with over 24 years of experience, is committed to providing consistent, high-quality histology services with quick turn-around times to the international scientific research community. Whether it is a pilot project requiring custom protocol development or a large-scale multi-timepoint drug efficacy study, each project is individually customized and undergoes the strictest of quality control measures before being presented back to you, our valuable client.


CNBE, a state-of-art laboratory animal facility fully accredited by the Canadian Council on animal care (CCAC) and AAALAC International, has expertise with many animal species from rodents to non-human primates including farm animals since 1995. CNBE has developed many animal models in different therapeutic areas (e.g. oncology, immunology, liver injury, endotoxemia), may develop models according to your concrete needs and offers non-GLP exploratory studies in toxicology, pharmacokinetic and biomarker discovery areas.


“Thanks to this agreement, the clients will be able to use the expertise of each organization to strengthen their drug development pipeline.” commented Mario C. Filion, Director of CNBE INRS.



CNBE, located on the INRS Research University campus in Laval, Québec, Canada, offers high standard preclinical research services to the scientific community and the biotechnology and pharmaceutical industries. Certified by the CCAC (Good Animal Practice®) and AAALAC International, it provides state-of-the-art housing for laboratory animals at various levels of biological confinement as well as an array of services required by R&D projects and drug development. At CNBE, we do not sell services, we offer solutions. For more information, please visit 


About Wax-it Histology Services

Wax-it Histology Services is a privately held, GLP accredited contract research organization (CRO) that provides general histopathology (paraffin and frozen), immunohistochemistry (general IHC, antibody testing/validation, cross-reactivity studies), GLP and non-GLP histopathology for preclinical toxicology studies, and resin/plastic histopathology for implantable medical devices and bone. The company works with clients within the Drug Development, Medical Device, Pharmaceutical, Government, and Academic sectors. For more information, visit



About the Author and BIOCOM CRO Board Member